decisionhealth Newsletters, Part B News - 2015 Issue 6 (June)
Between Q3 2014 to Q3 2015, four ASP drug prices rose by more than $1K
Subscribe or sign in to view the full article.
Article Overview
This piece reviews year-over-year changes in quarterly ASP drug prices and identifies the largest gainers in the Medicare drug pricing landscape. It is intended for coders, billing staff, reimbursement analysts, and others monitoring Part B drug pricing trends. The article presents broad comparative pricing movement, identifies the highest one-year increases, and discusses the overall mix of price changes among the most expensive drugs on the list.
Why This Topic Matters
Understanding large ASP price shifts helps coding and reimbursement professionals track drug payment trends and anticipate changes in claim processing or financial impact for high-cost medications.
What You Will Learn
- How the article compares ASP drug prices across two quarterly snapshots
- Which drugs had the largest year-over-year price increases
- How the article frames pricing movement among the highest-priced drugs
- What the article says about overall price direction across the reviewed list
Who Should Read This
- Medical coders
- Billing specialists
- Reimbursement analysts
- Payer policy staff
- Practice administrators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com